GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM99694
Query DataSets for GSM99694
Status
Public on Mar 05, 2007
Title
5SC-nbc
Sample type
RNA
Source name
subcutaneous fat
Organism
Mus musculus
Characteristics
db/db mice
Extracted molecule
total RNA
Label
biotin
Description
male mice (8 wks) were treated (oral gavage) with niacin bound chromium (nbc; 10 mg/kg wt) in water for 10 weeks (5d per wk). At the end of study subcutaneous fat was harvested for microarray analysis.
Data processing
MAS 5.0
Submission date
Mar 08, 2006
Last update date
Mar 09, 2006
Contact name
Sashwati Roy
E-mail(s)
[email protected]
Organization name
Ohio State University
Department
Surgery
Lab
Mol Med
Street address
473 W. 12th Av
City
Columbus
State/province
OH
ZIP/Postal code
43210
Country
USA
Platform ID
GPL1261
Series (1)
GSE4420
Diabetic mice fat- niacin bound chromium
Data table header descriptions
ID_REF
VALUE
signal
ABS_CALL
detection call
DETECTION P-VALUE
p value
Data table
ID_REF
VALUE
ABS_CALL
DETECTION P-VALUE
AFFX-BioB-5_at
2062.2
P
0.000446
AFFX-BioB-M_at
4534.9
P
0.000044
AFFX-BioB-3_at
1982.2
P
0.00011
AFFX-BioC-5_at
9249.7
P
0.000044
AFFX-BioC-3_at
10052
P
0.000044
AFFX-BioDn-5_at
14446.7
P
0.000044
AFFX-BioDn-3_at
30922.7
P
0.000044
AFFX-CreX-5_at
80956
P
0.000052
AFFX-CreX-3_at
96814.8
P
0.000044
AFFX-DapX-5_at
96.2
A
0.455413
AFFX-DapX-M_at
84.6
A
0.52976
AFFX-DapX-3_at
42.8
A
0.5
AFFX-LysX-5_at
6
A
0.953533
AFFX-LysX-M_at
101.3
A
0.5
AFFX-LysX-3_at
152.7
P
0.018281
AFFX-PheX-5_at
23.4
A
0.686277
AFFX-PheX-M_at
13
A
0.876428
AFFX-PheX-3_at
264.6
A
0.175328
AFFX-ThrX-5_at
90.1
A
0.617401
AFFX-ThrX-M_at
102.4
A
0.382599
Total number of rows:
45101
Table truncated, full table size
1237 Kbytes
.
Supplementary data files not provided
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|